<< Wolverine Venture Fund to participate in Direct Flow Medical's Series C round of financing | XTend Medical provides update regarding the BioHarp market potential >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Noveko International closes initial amount of $11.7 million private placement

Published on October 12, 2009 at 8:54 AM · No Comments

Noveko International Inc. ("the Company") is pleased to announce the closing of an initial amount of $11.7 million (the "first Closing") of its previously announced best efforts private placement (the "Offering"). It is expected that a second and final closing of the Offering will occur no later than October 30, 2009.

Pursuant to the first Closing, each Unit was offered at $2.20 and consisted of one (1) Class A share of the Company (a "Class A Share") and one-half of one Class A Share purchase warrant (each whole Class A Share purchase warrant, a "Warrant"). Each Warrant entitles its holder to purchase, at a price of $3.00 per share, one Class A Share for a period of 36 months following the first Closing, subject to acceleration as described below. Accordingly, a total of 5,301,000 Class A shares were issued by the Company and an additional 2,650,500 Class A shares may be issued upon due exercise of the Warrants. Also, the option previously granted by the Company to the Agents (the "Agents' Option") was modified and is now exercisable at any time up to 30 days following the first Closing.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading